Press release
Hemophilia Market Size, Share, Trends, Analysis and Forecast 2020-2026
The global hemophilia market is anticipated to grow with a significant CAGR of 6% during the forecast period. The hemophilia market growth is owing to the increasing demand for the prophylactic treatment of hemophilia. In addition to this, the increasing engagement of healthcare professionals, hemophilia treatment centers, as well as hemophilia societies to improve the care of hemophilia patients and their quality of life is also expected to drive the hemophilia market shares. Moreover, the continuous evolving treatment of hemophilia in recent years is also anticipated to propel the growth of the hemophilia market.A full report of Hemophilia Market is available at: https://www.omrglobal.com/industry-reports/hemophilia-market
In general, the treatment of monogenetic bleeding disorders that is hemophilia A and B was done with the systemic protein replacement therapy. However, in recent years, a variety of diverse molecular medicines, ranging from antibody to gene to RNA therapy are transforming the treatment of hemophilia.
Moreover, the traditional replacement therapy used in the treatment of hemophilia required intravenous infusions of the factors for two to three times a week. While the new therapies in the market with extended half-life products are expected to reduce the frequency of injections. Additionally, multiple gene-editing techniques are under clinical or preclinical investigation for the treatment of hemophilia. Therefore, these new therapies and approaches that are being tested or launched are anticipated to considerably drive the size of the hemophilia industry during the forecast period.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hemophilia-market
In addition to this, several potential drugs can be used for the treatment of hemophilia are in their trials phase. These potential drugs are anticipated to provide new opportunities for the growth of the hemophilia market upon their market launch. For instance, Fitusiran an RNA-interference drug is in its Phase III trials. It is intended to be once a month injection that can both inhibits antithrombins and promotes the production of thrombin. Fitusiran can be used in both hemophilia A as well as hemophilia B treatment. Moreover, in January 2020 Sangamo Therapeutics has handed over the development of SB-525, (a gene therapy for hemophilia A), to Pfizer Inc. The company will now advance the therapy into Phase 3 clinical trials.
Global Hemophilia Market- Segmentation
By Type
• Hemophilia A
• Hemophilia B
• Others
By Therapy
• Replacement Therapy
• Gene Therapy
• Others
By Product Type
• Recombinant Coagulation Factor Concentrates
• Plasma-derived Coagulation Factor Concentrates
• Others
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/hemophilia-market
Global Hemophilia Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Alnylam Pharmaceuticals, Inc
• Baxter International, Inc.
• Bayer AG
• BioMarin Pharmaceutical Inc.
• Biotest AG
• Catalyst Biosciences Inc.
• CSLLtd.
• Emergent BioSolutions Inc.
• F. Hoffmann-La Roche Ltd.
• GC Pharma (Green Cross Corp.)
• Genentech Inc. (HEMLIBRA)
• Grifols, S.A.
• Kedrion S.p.A
• Medexus Pharmaceuticals, Inc.
• Nektar Therapeutics
• Novo Nordisk A/S
• Octapharma AG
• Pfizer, Inc.
• Sanofi SA
• Spark Therapeutics, Inc.
• Swedish Orphan Biovitrum AB
• Takeda Pharmaceutical Company Ltd.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hemophilia Market Size, Share, Trends, Analysis and Forecast 2020-2026 here
News-ID: 2150102 • Views: …
More Releases from Orion Market Research
Environment Conservation and Wildlife Organization Market Rising Demand and Grow …
In 2023, the global market for environment, conservation, and wildlife organizations was approximately USD 26.2 billion, and by 2033, it is projected to reach around USD 41.5 billion, reflecting a compound annual growth rate (CAGR) of approximately 5.0% from 2024 to 2033.
Environment Conservation and Wildlife Organization Market Overview
The environment, conservation, and wildlife organizations market is experiencing steady growth, driven by increasing public awareness of environmental issues and the need for…
Wooden Furniture Market Size Analysis, Competitive Insights, Leading Players and …
In 2023, the global wooden furniture market was valued at approximately USD 235.3 billion, and by 2033, it is projected to reach around USD 327.7 billion, reflecting a compound annual growth rate (CAGR) of approximately 3.4% from 2024 to 2033.
Wooden Furniture Market Overview
The global wooden furniture market is experiencing steady growth, driven by increasing consumer demand for sustainable and aesthetically pleasing home furnishings. Factors such as rising disposable incomes, urbanization,…
Warehouse Management Systems Market Size Analysis, Competitive Insights, Leading …
In 2023, the global Warehouse Management Systems (WMS) market was approximately USD 3.2 billion, and by 2033, it is expected to reach around USD 9.4 billion, reflecting a compound annual growth rate (CAGR) of approximately 11.4% from 2024 to 2033.
Warehouse Management Systems Market Overview
The Warehouse Management Systems (WMS) market is rapidly growing as businesses increasingly seek to optimize their supply chain and inventory management processes. WMS solutions help improve operational…
Space Technology Market Rising Demand and Growth Forecast Through 2033
The global space technology market was valued at approximately USD 443.20 billion in 2023, and is projected to grow to about USD 916.85 billion by 2033, representing a compound annual growth rate (CAGR) of roughly 7.54% during the period from 2024 to 2033.
Space Technology Market Overview
The space technology market is experiencing strong expansion, driven by a surge in satellite innovation, advances in launch systems, and a growing wave of commercial…
More Releases for Hemophilia
Rising Occurrence Of Genetic Abnormalities Fuels Hemophilia Market Growth: Stren …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Hemophilia Market Through 2025?
In recent times, there has been a significant expansion in the hemophilia market. The market, which stood at $13.83 billion in 2024, is projected to inflate to $15.13 billion in 2025, exhibiting a compound annual growth rate (CAGR)…
Global Hemophilia Market Size & Trends
According to a new market research report published by Global Market Estimates, the global hemophilia market is projected to grow at a CAGR of 6.8% from 2023 to 2028.
During the forecast period, the global hemophilia market is anticipated to experience growth due to advancements in medical research, an increase in hemophilia incidence, and rising awareness and diagnosis.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and…
Acquired Hemophilia Treatment Market - Embracing Hope, Defying Hemophilia: Trans …
Newark, New Castle, USA: The "Acquired Hemophilia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Acquired Hemophilia Treatment Market: https://www.growthplusreports.com/report/acquired-hemophilia-treatment-market/7748
This latest report researches the industry structure,…
Hemophilia Market
Hemophilia is an inherited genetic syndrome which impairs body-2019s capability to control blood clotting or coagulation. The episodes of bleeding mainly depend on the severity of hemophilia issue. There are two major kinds of hemophilia namely Hemophilia A & Hemophilia B. Hemophilia A is considered to be five times more prevailing as compared to hemophilia B. Occurrence of hemophilia A is found in one out of five or six thousand…
Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Koval …
ReportsWorldwide has announced the addition of a new report title Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Kovaltry, Feiba), By Type of Hemophilia (Hemophilia A, Hemophilia B), By Treatment (On-Demand, Prophylaxis), By Therapy (Replacement , Immune Tolerance Induction ) Outlook 2022 to its growing collection of premium market research reports.
Hemophilia is an inherited bleeding disorder that slows the blood clotting process. The people suffering from this condition experience prolonged…
In-depth analysis of the Global Hemophilia Market: hemophilia A, hemophilia B, h …
Latest industry research report on: Global Hemophilia Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Request For Sample Report @ http://www.marketresearchreports.biz/sample/sample/1064504
The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder causes…
